Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical Misses on Revenue, Stock Down 0.93%

Collegium Pharmaceutical reported a loss of $0.14 per share, which was slightly better than expected. However, the lack of revenue figures and management commentary may have contributed to the stock's decline of 0.93%. Investors will likely be looking for more information in future reports to gauge the company's performance and direction.